Drug cost avoidance analysis of cancer clinical trials in Spain: a study on cost contributors and their impact

• المؤلفون الرئيسيون: Domingo Antonio Sánchez Martínez (مؤلف), Federico Salas-Lucia (مؤلف), Hanzi Jiang (مؤلف), Paula Ruiz-Carreño (مؤلف), José Luis Alonso Romero (مؤلف)
• التنسيق: كتاب
• منشور في: BMC, 2022-07-01T00:00:00Z.
• الموضوعات: article
• الوصول للمادة أونلاين: Connect to this object online.

Abstract Objective Analyze the cost contributors and their impact on the drug cost avoidance (DCA) resulting from cancer clinical trials over the period of 2015-2020 in a tertiary-level hospital in Spain (HCUVA). Methods We performed a cross-sectional, observational, retrospective study of a total o...